# Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers

> **NCT00934453** · PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 50 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** Lactobacillus rhamnosus GG ATCC 53103
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT00934453
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2017-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00934453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00934453, "Safety of Lactobacillus Rhamnosus GG ATCC 53103 (LGG) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00934453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*